Search results for "Cardiac"

showing 10 items of 1495 documents

Prognostic value of Morise clinical score, calcium score and computed tomography coronary angiography in patients with suspected or known coronary ar…

2011

Our aim was to determine the prognostic value of computed tomography coronary angiography (CTCA), coronary artery calcium scoring (CACS) and Morise clinical score in patients with known or suspected coronary artery disease (CAD). A total of 722 patients (480 men; 62.7 +/- 10.9 years) who were referred for further cardiac evaluation underwent CACS and contrast-enhanced CTCA to evaluate the presence and severity of CAD. Of these, 511 (71%) patients were without previous history of CAD. Patients were stratified according to the Morise clinical score (low, intermediate, high), to CACS (0-10, 11-100, 101-400, 401-1,000, > 1,000) and to CTCA (absence of CAD, nonsignificant CAD, obstructive CAD…

Coronary angiographyMalemedicine.medical_specialtyCoronary Artery DiseaseCoronary AngiographyMorise scoreRisk AssessmentSensitivity and SpecificitySeverity of Illness IndexComputed tomography coronary angiographyCoronary artery diseaseSDG 3 - Good Health and Well-beingPredictive Value of TestsRisk FactorsInternal medicineSeverity of illnessmedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesSurvival analysisNeuroradiologyAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryCalcinosisRetrospective cohort studyInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival AnalysisCalcium scoreComputed tomography coronary angiography Prognostic value Prognosis Calcium score Morise scorePredictive value of testsCardiologyFemaleRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessTomography X-Ray ComputedPrognostic valueCARDIAC CTAlgorithmsFollow-Up Studies
researchProduct

Low dose CT of the heart: a quantum leap into a new era of cardiovascular imaging.

2010

In 10 years, computed tomography coronary angiography (CTCA) has shifted from an investigational tool to clinical reality. Even though CT technologies are very advanced and widely available, a large body of evidence supporting the clinical role of CTCA is missing. The reason is that the speed of technological development has outpaced the ability of the scientific community to demonstrate the clinical utility of the technique. In addition, with each new CT generation, there is a further broadening of actual and potential applications. In this review we examine the state of the art on CTCA. In particular, we focus on issues concerning technological development, radiation dose, implementation,…

Coronary angiographymedicine.medical_specialtyCardiologyComputed tomographycardiac CTCoronary DiseaseCoronary AngiographyRadiation DosageCoronary artery diseaseComputed tomography coronary angiographyCoronary artery diseasemedicineTrainingLow dose ctHumansRadiology Nuclear Medicine and imagingMedical physicsNeuroradiologymedicine.diagnostic_testEquipment Safetybusiness.industryRadiation doseRadiation doseGeneral MedicineConventional coronary angiographymedicine.diseaseComputed tomography coronary angiography Conventional coronary angiography Coronary artery disease Radiation dose TrainingClinical realitySafety EquipmentbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaRadiologyTomography X-Ray ComputedLa Radiologia medica
researchProduct

Severe iatrogenic admissions in a coronary care unit:

2013

Introduction: Iatrogenic complications are defined as adverse drug reactions or complications induced by non drug interventions, such as cardiac devices or stimulation techniques. Iatrogenic complications occurring during hospital stay are known to be associated with increased hospital length of stay and mortality. Only few data are available on iatrogenic as cause of hospital admission, particularly in coronary care unit. In patient admitted in coronary care unit for iatrogenic, we aimed a) to analyse their prevalence, type and characteristics, b) to analyse their in-hospital length of stay and mortality and c) to evaluate the predictive factors of severity and mortality. Methods: From 1st…

Coronary angiographymedicine.medical_specialtyDigoxinbusiness.industryAmiodaroneCardiac surgerySurgeryInternal medicineVasoactiveHospital admissionmedicineCoronary care unitCardiology and Cardiovascular MedicinebusinessNon pharmacologicalmedicine.drugEuropean Heart Journal
researchProduct

CT coronary angiography at an ultra-low radiation dose (< 0.1 mSv): feasible and viable in times of constraint on healthcare costs

2013

Computed tomography coronary angiography (CTCA) has reached very high standards both in terms of diagnostic performance and radiation dose reduction. This commentary follows a report on CTCA using less than 0.1 mSv in selected patients. This is an extraordinary accomplishment, both for technology and for medicine. The difficult task is now to implement this tool in clinical practice so it can play the best possible role. CTCA can improve diagnostic pathways, can save money for healthcare systems and could even improve pharmacological therapy. All of this may happen, but it will require the combined effort of all the experienced operators in this field, including the referring clinicians. In…

Coronary angiographymedicine.medical_specialtylow radiation dosePharmacological therapyCT coronary angiographyCoronary Artery DiseaseCoronary AngiographyRadiation DosageSensitivity and Specificityhealthcare costsRadiation ProtectionHealth careCardiac CTHumansMedicineLow dose ctRadiology Nuclear Medicine and imagingMedical physicsConstraint (mathematics)Neuroradiologymedicine.diagnostic_testbusiness.industryscreeningRadiation doseReproducibility of ResultsInterventional radiologyHealth Care CostsGeneral MedicineUnited StatesFeasibility StudiesRadiologyTomography X-Ray ComputedbusinessEuropean Radiology
researchProduct

Coronary anomalies

2011

Coronary anomaliecardiac CTSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology a…

2016

ABI : ankle–brachial (blood pressure) index ABPM : ambulatory blood pressure monitoring ACCORD : Action to Control Cardiovascular Risk in Diabetes ACE-I : angiotensin-converting enzyme inhibitor ACS : acute coronary syndromes ADVANCE : Action in Diabetes and Vascular disease: PreterAx

Cost-Benefit AnalysisGeneral Practice030204 cardiovascular system & hematologyGuidelineDiabete0302 clinical medicineHyperlipidemiaStakeholderMedicine030212 general & internal medicineMultiple Chronic ConditionsPractice Patterns Physicians'Societies MedicalRisk assessmenteducation.field_of_studyCardiac RehabilitationDiabetesRehabilitationSmokingPsychosocial factorAge FactorsLipidMiddle AgedPrimary carePedigreeEuropeCardiovascular DiseasesPsychosocial factorsHypertensionBlood pressureDiet HealthyRisk assessmentCardiology and Cardiovascular MedicineAdultDiagnostic Imagingmedicine.medical_specialtyAmbulatory blood pressurePopulationPopulationCardiologyHealthy lifestyleHyperlipidemiasHealth PromotionDiabetic angiopathyGuidelinesRisk Assessment03 medical and health sciencesSex FactorsDiabetes mellitusJournal ArticleHumansClinical settingsHealthy LifestyleIntensive care medicineeducationExerciseAntihypertensive AgentsNutritionAgedbusiness.industryVascular diseasePhysical activityPreventionmedicine.diseasebody regionsClinical settingBlood pressureRisk managementSocioeconomic FactorsSmoking CessationJoint Esc GuidelinesbusinessBiomarkersDiabetic Angiopathies
researchProduct

Familial hypercholesterolæmia in children and adolescents: Gaining decades of life by optimizing detection and treatment

2015

Contains fulltext : 155263.pdf (Publisher’s version ) (Open Access) Familial hypercholesterolaemia (FH) is a common genetic cause of premature coronary heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and treated early in childhood, individuals with FH can have normal life expectancy. This consensus paper aims to improve awareness of the need for early detection and management of FH children. Familial hypercholesterolaemia is diagnosed either on phenotypic criteria, i.e. an elevated low-density lipoprotein cholesterol (LDL-C) level plus a family history of elevated LDL-C, premature coronary artery disease and/or genetic diagnosis, or positive genetic testin…

CounselingEuropean Atherosclerosis Society Consensus PanelPediatricsCardiac & Cardiovascular SystemsSTATIN THERAPYSettore MED/09 - Medicina InternaVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Familial hypercholesterolemiaAdolescentsCarotid Intima-Media ThicknessINTIMA-MEDIA THICKNESSCost of IllnessPregnancyRisk FactorsDiagnosisYOUNG-ADULTSHIPERCOLESTEROLEMIA (DIAGNÓSTICO;TERAPIA;TENDÊNCIAS)Family historyYoung adultChildChildrenEvidence-Based Medicinemedicine.diagnostic_testHomozygoteMiddle AgedFamilial hypercholesterolæmia3. Good healthEconomics MedicalAdolescents; Children; Consensus statement; Diagnosis; Ezetimibe; Familial hypercholesterolæmia; LDL cholesterol; PCSK9 inhibitor; Statin; Treatment; Cardiology and Cardiovascular MedicineCARDIOVASCULAR-DISEASEConsensus statementLDL cholesterolFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineFamilial hypercholesterolaemiaLife Sciences & BiomedicineDiagnosimedicine.drugAdultHeterozygotemedicine.medical_specialtyStatinAdolescentmedicine.drug_classPCSK9 inhibitorENDOTHELIAL FUNCTIONLOW-DENSITY-LIPOPROTEINReviewsCOST-EFFECTIVENESS ANALYSIS1102 Cardiovascular Medicine And HaematologyMedication AdherenceHyperlipoproteinemia Type IIYoung AdultLife ExpectancyEzetimibemedicineHumansCORONARY-HEART-DISEASEGenetic TestingGenetic testingPregnancyScience & TechnologyClinical Laboratory Techniquesbusiness.industryPreventionStatinAtherosclerosismedicine.diseaseEzetimibeDietASSOCIATION EXPERT PANELBLOOD-PRESSURE RESEARCHPregnancy ComplicationsTreatmentEarly DiagnosisIntima-media thicknessCardiovascular System & HematologyDietary SupplementsPhysical therapyCardiovascular System & Cardiologybusiness
researchProduct

Impact of a stay in the intensive care unit on the preparation of Advance Directives: Descriptive, exploratory, qualitative study.

2017

Abstract Background Our objective was to assess, through a qualitative, exploratory study, the thought processes of patients regarding the formulation of advance directives (AD) after a stay in the ICU. Methods The study was conducted from May to July 2016 using telephone interviews performed by four senior ICU physicians. Inclusion criteria were: patients discharged from ICU to home > 3 months earlier. Semi-directive interviews with patients focused on 5 main points surrounding AD. Results In total, among 159 eligible patients, data from 94 (59%) were available for analysis. Among all those interviewed, 83.5% had never heard of “advance directives”. Only 2% had executed AD before ICU admis…

CounselingMalemedicine.medical_specialtyCritical Caremedicine.medical_treatmentIntensive Care UnitExploratory researchCritical Care and Intensive Care MedicineAdvanced Cardiac Life SupportAdvance directiveslaw.invention03 medical and health sciences0302 clinical medicinelawSurveys and QuestionnairesmedicineHumans030212 general & internal medicineAgedMechanical ventilationAged 80 and overbusiness.industryPersistent Vegetative StateAdvanced cardiac life supportMinimally conscious state030208 emergency & critical care medicine[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineMiddle Agedmedicine.diseaseIntensive care unit3. Good healthIcu admissionPain IntractableTelephoneIntensive Care UnitsAnesthesiology and Pain MedicineEmergency medicineFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieQualitative studybusinessInclusion (education)Medical FutilityVentilator WeaningQualitative research
researchProduct

Relative incidence and mortality of congenital heart defects diagnosed by angiohemodynamic methods: a 17-year study.

1992

Over a 17-year period (January 1971 to January 1988), 2322 children, aged 0-14 years, were diagnosed as having congenital heart disease (CHD) by cardiac catheterization and angiography. Excluding those with highly complex or undiagnosed defects, there were 2156 children with CHD, 72.4% of whom were treated surgically, with a total surgical mortality rate of 24.1%. After a mean follow-up of 9 years the overall mortality of the cohort was 29.9%, 29.1% occurring in the first month of life, 39.6% between 1 month and 1 year, and 31.2% between 1 and 14 years. The incidence, mortality, and age at death of each cardiac defect are presented and compared with the results of other studies. The overall…

Cross-Cultural ComparisonHeart Defects CongenitalMalePediatricsmedicine.medical_specialtyCardiac CatheterizationHeart diseaseAdolescentRelative incidencemedicine.medical_treatmentCohort StudiesPostoperative ComplicationsmedicineHumansChildCardiac catheterizationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)AngiocardiographyPalliative CareHemodynamicsInfant NewbornInfantVascular surgerymedicine.diseaseCardiac surgerySurvival RateSpainChild PreschoolPediatrics Perinatology and Child HealthCohortAngiographyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPediatric cardiology
researchProduct

Collateral findings

2011

Ct Coronary Angiography. ImagingCt Coronary Angiography. Imaging; RadiologyCollateral findingcardiac CTSettore MED/36 - Diagnostica Per Immagini E RadioterapiaRadiology
researchProduct